4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide (STI) Summary

Clusters summary
Clustering method gromos
Clustering metric RSMdi
Initial clustering cutoff (nm) 0.05
Final clustering cutoff (nm) 0.115
Number of clusters 30
Number of clusters representing 95% 8
Cluster Population
Clusters Convergence
ΔG WITH RESPECT TO BIOACTIVE CONFORMATION
ΔGdist (kcal/mol) 1.3290
ΔGstrain (kcal/mol) 0.4679
Conformations Table
ClNum ClPop ΔG Cl-Cl RMSd Exp
1 2336 0 2.2413
2 1306 0.3443 1.5406
3 1271 0.3604 2.6696
4 1250 0.3702 2.2845
5 1166 0.4114 2.752
6 1060 0.4679 1.3656
7 747 0.6751 1.4775
8 642 0.7648 2.4256
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)